IrvingKentLohMDFACC FAHA FCCP FACP

PubMed

• 9 citations
  Moexipril versus captopril in patients with mild to moderate hypertension.
  Michael Stimpel, Brigitte Koch, Thomas Jansen, Alanna A.L. Fox, Irving Loh> ;Journal of Cardiovascular Pharmacology. 1996 Dec 1
• 10 citations
  Secondary prevention and lipid lowering: Results and implications
  Katherine M. Detre, Robert I. Levy, Sheryl F. Kelsey, Stephen E. Epstein, John F. Brensike, Eugene R. Passamani, John M. Richardson, Irving K. Loh, Neil J. Stone, Robe...> ;American Heart Journal. 1985 Nov 1
• 327 citations
  The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention S...
  Robert I. Levy, John F. Brensike, Stephen E. Epstein, S. F. Kelsey, Eugene R. Passamani, John M. Richardson, Irving K. Loh, Neil J. Stone, Robert F. Aldrich, James W. ...> ;Circulation. 1984 Feb 1
• 489 citations
  Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.
  John F. Brensike, Robert I. Levy, S. F. Kelsey, Eugene R. Passamani, John M. Richardson, Irving K. Loh, Neil J. Stone, Robert F. Aldrich, James W. Battaglini, Daniel J...> ;Circulation. 1984 Feb 1
• 2 citations
  Simultaneous assessment of segmental and global left ventricular function by two-dimensional echocardiography in acute myocardial infarction.
  Yzhar Charuzi, Robert M. Davidson, M. J. Barrett, Clain Beeder, Lorraine A. Marshall, Irving K. Loh, J. A. Prause, Samuel Meerbaum, Eliot Corday> ;Clinical Cardiology. 1983 Jun 1
• 42 citations
  Early diagnosis of nontransmural myocardial infarction by two-dimensional echocardiography☆
  Irving K. Loh, Yzhar Charuzi, Clain Beeder, Lorraine A. Marshall, Jerry H. Ginsburg> ;American Heart Journal. 1982 Nov 1
• 36 citations
  Reliability of assessing change with sequential coronary angiography
  Katherine M. Detre, Sheryl F. Kelsey, Eugene R. Passamani, Marian R. Fisher, John F. Brensike, James W. Battaglini, John M. Richardson, Irving K. Loh, Neil J. Stone, R...> ;American Heart Journal. 1982 Oct 1
• 30 citations
  National heart, lung, and blood institute type II coronary intervention study: Design, methods, and baseline characteristics☆
  John F. Brensike, Sheryl F. Kelsey, Eugene R. Passamani, Marian R. Fisher, John M. Richardson, Irving K. Loh, Neil J. Stone, Robert F. Aldrich, James W. Battaglini, Da...> ;Controlled Clinical Trials. 1982 Jun 1
• 8 citations
  Relationship between segmental abnormalities and global left ventricular function in coronary artery disease: Validation of a theoretical model
  Clain Beeder, Yzhar Charuzi, Irving K. Loh, Howard M. Staniloff, H.J.C. Swan> ;American Heart Journal. 1981 Sep 1
• 50 citations
  Coronary calcifications in the detection of coronary artery disease and comparison with electrocardiographic exercise testing. Results from the National Heart, Lung, a...
  R F Aldrich, John F. Brensike, J W Battaglini, John M. Richardson, Irving K. Loh, Neil J. Stone, Eugene R. Passamani, H Ackerstein, Ronald P. Seningen, Jeffrey S. Bore...> ;Circulation. 1979 Jun 1
• Join now to see all

Journal Articles

• A Dose-Dependent Increase in Mortality with Vesnarinone Among Patients with Severe Heart Failure.  
  Vesnarinone Trial Investigators, New England Journal of Medicine
• Hobbs RE. Results of the ATLAS Study – high or low doses of ACE inhibitors for heart failure?  
  ATLAS Trial Investigators, Cleve Clin J Med
• Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure.  
  ATLAS Study Group, Circulation
• Comparative Effects of Candesartan Cilexetil and Losartan in Patients with Systemic Hypertension.  
  CANDLE Trial Investigators, Heart Disease
• Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HR).  
  MERIT-HF Study Group, THE LANCET
• Clinical trials back growing use of beta-blockade in heart failure.  
  IK Loh, Cardiology Review
• Effect of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Interve...  
  MERIT-HF Study Group, JAMA
• Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Hypercholesterolaemia: the Pivotal Placebo- controlled Clinical Trial.  
  Cerivastatin Study Group, J International Medical Research
• Use of Simvastatin Treatment in Patients with Combined Hyperlipidemia in Clinical Practice.  
  Simvastatin Combined Hyperlipidemia Registry Group, Arch Fam Med
• Comparative Efficacy of Olmesartan, Losartan, Valsartan and Irbesartan in the Control of Essential Hypertension.  
  CS-866 Study Group, Journal of Clinical Hypertension
• Cardiovascular morbidity and mortality n the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol.  
  LIFE Study Group, THE LANCET
• Comparison of the Efficacy and Safety of Rosuvastatin Versus Atorvastatin, Simvastatin, and Pravastatin Across Doses (STELLAR Trial).  
  STELLAR Study Group, Am. J. Cardiol
• Comparison of the Efficacy of Rosuvastatin Versus Atorvastatin, Simvastatin, and Pravastatin in Achieving Lipid Goals; Results from the STELLAR Trial.  
  STELLAR Study Group, Current Medical Research and Opinions
• argeted Anticytokine Therapy in Patients with Chronic Heart Failure; Clinical Investigation and Reports.  
  RENEWAL Study Group, Circulation
• Information Technology at the Point- of-Care Will Improve Quality and Outcome: Methodology.  
  IK Loh, Sutherland J, Ash A, Circulation Supplement
• Dose-comparison Study of the Combination of Ezetimibe and Simvastatin Versus Atorvastatin in Patients with Hypercholesterolemia: the Vytorin Versus Atorvastatin Study.  
  VYVA Study Group, Am. Heart J
• Achieving LDL cholesterol, non-HDL cholesterol, and apoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastati...  
  Mercury II Study Group, Am. Heart J
• Exceptional early blood pressure control rates: The ACCOMPLISH trial.  
  Accomplish Investigators, Blood Pressure
• Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein.  
  JUPITER Study Group, New Engl. J. Med
• Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients with Stable Coronary Artery Disease.  
  ASSERT Study Group, J Am Coll Cardiol
• Coronary calcifications in the detection of coronary artery disease and comparison with electrocardiographic exercise testing.  
  RF Aldrich, Brensike JF, Battaglini JW, Richardson JM, Loh IK , Stone NJ, Passamani ER, Ackerstein H, Circulation
• The treatment of angina pectoris in Clinical Strategies in Ischemic Heart Disease`.  
  IK Loh and Corday E, Williams and Wilkins
• Limitation of infarction size: Is the concept feasible and assessable at the present time?  
  IK Loh and Corday E, Advances in Heart Disease. Grune and Stratton
• The rationale and necessity for randomized clinical trials for the evaluation of cardiac surgical procedures.  
  IK Loh, New England Journal of Medicine
• The relationships between segmental abnormalities and global left ventricular function in coronary artery disease: Validation of a theoretical model.  
  C Beeder, Charuzi Y, Loh IK, American Heart Journal
• Join now to see all

Abstracts/Posters

• Moexipril Versus Captopril in Patients with Mild to Moderate Hypertension.
  Loh IK, Tenth Scientific Meeting of the American Society of Hypertension; New York Hilton/Towers, New York, NY

Lectures

• What You Need to Know About Preventing Cancer? 
  Melissa Belle Ford, Director for Prevention and Early Detection, Univ of Texas, M.D. A...
• Relearning Optimism. 
  Terry Paulson, Ph.D
• Television Report: The Prevention of Heart Disease -a five part series. 
  the Ventura Heart Institute education and screening program; KEYT Evening News; Santa Barbara, CA
• Television Interview: Prevention of Heart Disease. 
  Medical Information Services, Inc (recorded for broadcast at KESQ-TV 3; Palm Desert, CA)
• Television Interview: Health Care Reform and the California Market - a two part series. 
  Directions” for Miller Communications, Medical Information Services, Inc; Palm Desert, CA
• Health Care Reform - Where is it now? 
  ANS of California Annual Spring Seminar; Westin South Coast Hotel, Costa Mesa, CA
• Health Care Reform - Now What? 
  Featured Speaker, Hewlett-Packard; Fullerton, CA
• Health Care Reform - Now What? 
  Featured Speaker, Hewlett-Packard; Van Nuys, CA
• The Cardiovascular Effects of Angiotensin II. 
  Lecture to primary care physicians; Camarillo, CA
• The Angiotensin II Receptor Antagonism . 
  Cardiac Care Committee, Los Robles Hospital; Thousand Oaks, CA
• Emergence of Angiotensin II Receptor Antagonism for the Treatment of Hypertension. 
  The Simi Valley Family Care Group; Simi Valley, CA
• The Current Status of Health Care Reform and the Rise of Managed Care. 
  Queen’s Health Systems, Hawaiian Medical Society and East Hawaii IPA sponsored Symposium on ...
• The Disease Management of Congestive Heart Failure in the Era of Managed Care. 
  Queen’s Health Systems, Hawaiian Medical Society and East Hawaii IPA sponsored Symposium ...
• Innovations in the Management of Heart Failure - Implications for Primary Care. 
  Grand Rounds; Wilcox Memorial Hospital; Kauai, HI
• Innovations in the First-Line Management of Hypertension. 
  Grand Rounds; Wahiawa General Hospital; Oahu, HI
• Innovations in the Management of Heart Failure in the Era of Managed Care - the Role of Disease Management. 
  Hawaii Medical Services Association; Pagoda Hotel; Honolulu, Oahu, HI
• Angiotensin Receptor Blockade and the Role of Endothelial Dysfunction in Cardiovascular Disease. 
  Irondequoit Country Club; Rochester, NY
• The Rise of Managed Care, Its Relationship to Health Care Reform & the Implications for Clinical Research. 
  4th Clinical Liaison Meeting; Collaborative Clinical Research; Hyatt Regency Chicago
• Roundtable Discussion: Angiotensin Receptor Blockade in Cardiovascular Disease. 
  Lawry’s; Beverly Hills, CA
• Innovations in the First-Line Management of Hypertension in the Setting of Managed Care. 
  Scientific Tele-Conference to six Foundation Care Centers; FH - HC Center,Roseville, CA
• The Role of Angiotensin Receptor Blockade in Cardiovascular Disease. 
  Grand Rounds; Regional Medical Center; San Jose, CA.
• The Current Status of Health Care Reform and the Implications for Senior Citizens as a Result of Congressional Actions. 
  Westlake Hospital Auxiliary; Westlake Village, CA
• Roundtable Discussion: Angiotensin Receptor Blockade; A New Tool for the Pharmacologic Management of Hypertension. 
  Gervais; San Jose, CA
• “Heart to Heart” - Prevention of Heart Disease in Senior Citizens. 
  Integrated Fitness Conference for Seniors 50+; Moorpark, CA
• Innovations in the Management of Heart Failure. 
  Scientific Conference; Los Robles Regional Medical Center; Thousand Oaks, CA
• Join now to see all

Other

• Innovations in pharmaceuticals 
  IK Loh, Street Journal
  http://online.wsj.com/article/
• Radio Interview: Health Care Reform: Initiatives to reduce federal impediments to the delivery of health care. 
  Loh IK
  The White House, Washington
• Risk Factors in Premature Coronary Disease (Interview by Deborah Norville) 
  Loh IK, Guest
  NBC Studios, New York